Ikari Akira, Matsumoto Satomi, Harada Hitoshi, Takagi Kuniaki, Hayashi Hisayoshi, Suzuki Yuichi, Degawa Masakuni, Miwa Masao
Department of Environmental Biochemistry and Toxicology, University of Shizuoka, 52-1 Yada, Shizuoka 422-8526, Japan.
J Cell Sci. 2006 May 1;119(Pt 9):1781-9. doi: 10.1242/jcs.02901. Epub 2006 Apr 11.
Although paracellin-1 (PCLN-1) is known to have a crucial role in the control of Mg2+ reabsorption in the kidney, the molecular pathways involved in the regulation of PCLN-1 have not been clarified. We used FLAG-tagged PCLN-1 to investigate these pathways further, and found that PCLN-1 is phosphorylated at Ser217 by protein kinase A (PKA) under physiological conditions in Madin-Darby canine kidney (MDCK) cells. PCLN-1 expression decreased Na+ permeability, resulting in a decrease in the transepithelial electrical resistance (TER). By contrast, PCLN-1 enhanced transepithelial Mg2+ transport. PKA inhibitors, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride (H-89) and myristoylated protein kinase A inhibitor 14-22 amide PKI, and an adenylate cyclase inhibitor, 2',5'-dideoxy adenosine (DDA), reduced the phosphoserine level of PCLN-1. The inhibitory effect of DDA was rescued by 8-bromoadenosine-3',5'-cyclic monophosphate (8-Br-cAMP). PKA and adenylate cyclase inhibitors decreased transepithelial Mg2+ transport and TER. Dephosphorylated PCLN-1 moved from detergent-insoluble to soluble fractions and was dissociated from ZO-1. A fusion protein of PCLN-1 with glutathione-S-transferase revealed that Ser217 was phosphorylated by PKA. Phosphorylated PCLN-1 was localized in the tight junction (TJ) along with ZO-1, whereas dephosphorylated PCLN-1 and the S217A mutant were translocated into the lysosome. The degradation of dephosphorylated PCLN-1 and S217A mutant was inhibited by chloroquine, a specific lysosome inhibitor. Thus, the PKA-dependent phosphorylation of Ser217 in PCLN-1 is essential for its localization in the TJ and transepithelial Mg2+ transport.
尽管已知紧密连接蛋白-1(PCLN-1)在肾脏镁离子重吸收控制中起关键作用,但参与PCLN-1调节的分子途径尚未阐明。我们使用FLAG标记的PCLN-1进一步研究这些途径,发现在生理条件下,Madin-Darby犬肾(MDCK)细胞中的PCLN-1在丝氨酸217位点被蛋白激酶A(PKA)磷酸化。PCLN-1的表达降低了钠离子通透性,导致跨上皮电阻(TER)降低。相比之下,PCLN-1增强了跨上皮镁离子转运。PKA抑制剂N-[2-(对溴肉桂酰胺基)乙基]-5-异喹啉磺酰胺二盐酸盐(H-89)和肉豆蔻酰化蛋白激酶A抑制剂14-22酰胺PKI以及腺苷酸环化酶抑制剂2',5'-二脱氧腺苷(DDA)降低了PCLN-1的磷酸丝氨酸水平。8-溴腺苷-3',5'-环磷酸(8-Br-cAMP)挽救了DDA的抑制作用。PKA和腺苷酸环化酶抑制剂降低了跨上皮镁离子转运和TER。去磷酸化的PCLN-1从去污剂不溶性组分转移到可溶性组分,并与紧密连接蛋白1(ZO-1)解离。PCLN-1与谷胱甘肽-S-转移酶的融合蛋白显示丝氨酸217被PKA磷酸化。磷酸化的PCLN-1与ZO-1一起定位于紧密连接(TJ),而去磷酸化的PCLN-1和S217A突变体则易位到溶酶体中。氯喹(一种特异性溶酶体抑制剂)抑制了去磷酸化的PCLN-1和S217A突变体的降解。因此,PCLN-1中丝氨酸217的PKA依赖性磷酸化对于其在TJ中的定位和跨上皮镁离子转运至关重要。